These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6982816)

  • 1. Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells.
    Forni G; Landolfo S; Giovarelli M; Whitmore AC; Herberman RB
    Eur J Immunol; 1982 Aug; 12(8):664-70. PubMed ID: 6982816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell lines with dual specificity for strong Mls and H-2 determinants.
    Molnar-Kimber KL; Webb SR; Sprent J; Wilson DB
    J Immunol; 1980 Dec; 125(6):2643-5. PubMed ID: 6159415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.
    Webb SR; Okamoto A; Sprent J
    J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
    J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants.
    DeKruyff RH; Ju ST; Laning J; Cantor H; Dorf ME
    J Immunol; 1986 Aug; 137(4):1109-14. PubMed ID: 2426352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of an I-A-restricted T cell clone with dual specificity for poly(Glu60Ala30Tyr10) (GAT) and Mlsa,dl.
    Jenkins MK; Melvold RW; Miller SD
    J Immunol; 1984 Aug; 133(2):616-22. PubMed ID: 6203970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
    Janeway CA; Katz ME
    J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-dependent, H-2-restricted cytolytic and noncytolytic T cell lines with specificity for minor histocompatibility antigens.
    Di Pauli R; Opalka B
    Eur J Immunol; 1982 May; 12(5):365-73. PubMed ID: 6178605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.